Skip to content
★ Sign in to follow
GA

Glenn A. Oclassen

Verrica Pharmaceuticals Inc.Paratek Pharmaceuticals, Inc.
Total declarations
15
Companies
2
▲ Purchases (5 ops.)
€203k
▼ Sales (0 ops.)
—

Latest filing published 31 Jan 2019 for Verrica Pharmaceuticals Inc..

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Glenn A. Oclassen: trading record in brief

Glenn A. Oclassen has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Paratek Pharmaceuticals, Inc. and Verrica Pharmaceuticals Inc. The record holds 15 filings, for trades running from 30 January 2009 to 28 January 2019.

On the market, this insider has only ever bought: 5 purchases, €203k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants and 4 option exercises.

A typical purchase (the median) is worth €43k.

Most recently, on 31 January 2019, the filings show a transaction in Verrica Pharmaceuticals Inc. The last purchase on record was published on 20 September 2011, which is 5,529 days ago. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Glenn A. Oclassen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations